News

The software-based intervention aims to reduce brain hypersensitivity in patients with migraine by modulating responses to environmental and internal stimuli through a 12-week program.
Tepylute is indicated for the treatment of adenocarcinoma of the breast or ovary . It is now supplied as a multiple-dose vial containing 100mg of thiotepa, in addition to the previously approved ...
HealthDay News — For patients with chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL), statin use is associated with improved survival, regardless of treatment employed, according ...
HealthDay News — Patients with psoriatic arthritis (PsA) have delays in diagnosis compared with those with rheumatoid arthritis (RA), according to a study published in the Annals of the Rheumatic ...
Two national datasets explored the relationship between pain and cigarette, e-cigarette, cannabis, and alcohol use in cancer survivors.
HealthDay News — Adverse pregnancy outcomes (APOs) mediate a small proportion of the association between prepregnancy obesity and cardiovascular disease (CVD) risk in midlife, according to a study ...
Researchers sought to determine 1-year outcomes in patients being treated with tirzepatide who have atrial fibrillation.
TLX101-CDx is an investigational positron emission tomography agent that targets the membrane transport proteins, LAT1 and LAT2.
Involvement of clinicians, including primary care physicians, endocrinologists, and rheumatologists, as appropriate, can ensure a comprehensive and personalized approach to managing osteoporosis and ...
The outbreak mainly affected members of communities with low measles vaccination coverage in New Mexico, Oklahoma, and Texas.
Increase seen in lifetime use among adults and adolescents; past-year use higher among young adults, older adults.
HealthDay News — On Tuesday, the US Department of Health and Human Services (HHS) announced that the government will invest $176 million in Moderna to expedite the creation of a pandemic influenza ...